APOBEC proteins have evolved as innate defenses against retroviral infections. Human immunodeficiency virus (HIV) encodes the Vif protein to evade human APOBEC3G; however, mouse retroviruses do not encode a Vif homologue, and it has not been understood how they evade mouse APOBEC3. We report here a murine leukemia virus (MuLV) that utilizes its glycosylated Gag protein (gGag) to evade APOBEC3. gGag is critical for infection of in vitro cell lines in the presence of APOBEC3. Furthermore, a gGag-deficient virus restricted for replication in wild-type mice replicates efficiently in APOBEC3 knockout mice, implying a novel role of gGag in circumventing the action of APOBEC3 in vivo.
bAPOBEC3 proteins are restriction factors that induce G¡A hypermutation in retroviruses during replication as a result of cytidine deamination of minus-strand DNA transcripts. However, the mechanism of APOBEC inhibition of murine leukemia viruses (MuLVs) does not appear to be G¡A hypermutation and is unclear. In this report, the incorporation of mA3 in virions resulted in a loss in virion reverse transcriptase (RT) activity and RT fidelity that correlated with the loss of virion-specific infectivity.A POBEC3G (hA3G) in humans and APOBEC3 (mA3) in mice are cytidine deaminases that act on single-stranded DNA during reverse transcription, resulting in G¡A hypermutation of newly synthesized proviral DNA (1, 2). Although exogenous murine leukemia viruses (MuLVs) are relatively insensitive to the actions of mA3 (2-7), several studies have reported partial inhibition of exogenous MuLVs after incorporation of mA3 (2,3,6,(8)(9)(10)(11). Furthermore, the finding that Rfv3, a resistance gene for Friend erythroleukemia, encodes mA3 and is responsible for a decreased infectious titer of the Friend MuLV (Fr-MuLV) (11-13) strongly suggests that mA3 inhibits the replication of exogenous MuLVs in vivo. Exogenous ecotropic MuLVs, such as the FrMuLV and Moloney MuLV (Mo-MuLV), are inhibited through mechanisms that do not appear to involve cytidine deamination (2, 9, 10). In this study, the effects of mA3 on the infectivity, reverse transcriptase (RT) activity, and frequency of mutations of the ecotropic MuLV CasFr KP were examined. Virion-associated mA3 suppresses CasFr KP MuLV infectivity. In order to examine the effects of mA3 incorporated into MuLV virions, we derived clonal cell lines infected with CasFr KP (14). The 3T3mA3 cells were derived by transfection of a plasmid encoding the full-length mA3 derived from the BALB/c mouse strain and was tagged at the C termini with hemagglutinin (HA) (5). Infected clonal cell lines were obtained from 3T3 cells as well as from 3T3 cells expressing mA3 (3T3mA3) and were designated 3T3/CasFr KP and 3T3mA3/CasFr KP , respectively. In agreement with earlier reports (2, 7, 9, 13, 15), the clonal cell line expressing mA3 (3T3mA3/CasFr KP ) released virions that had incorporated an easily detectable level of mA3 (Fig. 1).The infectivity of CasFr KP containing mA3 was compared to that of CasFr KP devoid of mA3 by a focal immunofluorescence assay (FIA) (16) and normalized for virion number using the level of p30 CA protein (Fig. 2A). The specific infectivity of virions released from cells expressing mA3 exhibited over a 90% reduction in infectivity (Fig. 2B), corroborating earlier studies of inhibition by mA3 (2,3,6,(8)(9)(10)(11).Decrease in RT activity in virions containing mA3. A recent study examined the efficiency of virion reverse transcription by monitoring the appearance of strong-stop DNA during the course of the RT reaction using virions isolated from C57BL/6 and BALB/c mice as well as those from mA3 knockout (KO) mice (17). Both mouse strains exhibited a similar decrease in RT activity...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.